Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.
| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc. | Trofinetide - (Japan study) | Rett syndrome | Phase 3 | Ongoing | Oral | Genetic Disorder |
| ACADIA Pharmaceuticals Inc. | ACP-044 | Postoperative pain following bunionectomy surgery | Phase 2 | Data Released | Oral | Non-Opioid Analgesic |
| ACADIA Pharmaceuticals Inc. | Remlifanserin (ACP-204) - (RADIANT) | Alzheimer's disease psychosis | Phase 2 | Enrollment Initiation | Oral | Psychiatric |
| ACADIA Pharmaceuticals Inc. | NUPLAZID (pimavanserin) CLARITY-2 and CLARITY-3 | Adjunctive Treatment in Patients With Major Depressive Disorder | Phase 3 | Trial Discontinued | Oral | Psychiatric |
| ACADIA Pharmaceuticals Inc. | ACP-044 | Pain associated with osteoarthritis | Phase 2 | Trial Planned | Oral | Non-Opioid Analgesic |
| ACADIA Pharmaceuticals Inc. | ACP-044 | Pain associated with osteoarthritis | Phase 2 | Trial Planned | Oral | Non-Opioid Analgesic |
| ACADIA Pharmaceuticals Inc. | ACP-044 | Postoperative pain following bunionectomy surgery | Phase 2 | Data Released | Oral | Non-Opioid Analgesic |
| Achieve Life Sciences Inc. | Cytisinicline - (ORCA-3) | Smoking cessation of cigarettes | PDUFA | Ongoing | Oral | Anti-Addiction |
